Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Higher DHEA-S levels in hirsute females affect hair growth phases.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Finasteride helps hair growth by reducing DHT levels.

The normal human prostate does not significantly affect blood DHT levels.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

PCOS has many symptoms, with high androgen levels being the most common.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Surgery on a 68-year-old woman with an ovarian tumor led to reduced hirsutism and normal testosterone levels.

Cyproterone acetate temporarily reduces hair growth in women with idiopathic hirsutism but doesn't change hormone levels.

Hirsutism, excessive male-pattern hair in women, can be caused by high androgens or skin sensitivity, diagnosed by testosterone levels, and treated with hair removal and hormone therapy.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Testosterone raises blood pressure by affecting kidney function and brain gene regulation over time.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

A rare adrenal tumor in a 14-year-old girl caused male-like symptoms and was successfully removed.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.